Obicetrapib lowers LDL-C in patients on high intensity statins: Results from the rose trial (NCT04753606)
Autor: | Ray, K.K., Nicholls, S., Ditmarsch, M., Kastelein, J.J., Rigby, S., Kling, D., Curcio, D., Alp, N., Davidson, M. |
---|---|
Zdroj: | In Atherosclerosis August 2022 355 |
Databáze: | ScienceDirect |
Externí odkaz: |